19-49635634-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000246792.4(RRAS):c.599C>T(p.Pro200Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000235 in 1,449,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P200S) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000246792.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RRAS | NM_006270.5 | c.599C>T | p.Pro200Leu | missense_variant | 6/6 | ENST00000246792.4 | NP_006261.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RRAS | ENST00000246792.4 | c.599C>T | p.Pro200Leu | missense_variant | 6/6 | 1 | NM_006270.5 | ENSP00000246792 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152144Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000306 AC: 5AN: 163478Hom.: 0 AF XY: 0.0000229 AC XY: 2AN XY: 87398
GnomAD4 exome AF: 0.0000239 AC: 31AN: 1296772Hom.: 0 Cov.: 31 AF XY: 0.0000268 AC XY: 17AN XY: 634078
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152262Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74440
ClinVar
Submissions by phenotype
Noonan syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 12, 2022 | This variant has not been reported in the literature in individuals affected with RRAS-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is present in population databases (rs761629413, gnomAD 0.008%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 200 of the RRAS protein (p.Pro200Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at